Skip to Content

News: Cancer News

Cancer therapies’ impact on heart, kidneys explored

Thursday, September 24th, 2015

Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys. In recent years, kinase inhibitors have emerged as important options for treating many cancers. In particular, specific kinase inhibitors, called angiogenesis (or VEGF) inhibitors, target the tumor vasculature and have become options for […]

Strong scores put VICC among top NCI centers

Thursday, September 17th, 2015

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). High programmatic scores and the overall merit rating led to […]

Hach shows age not always a barrier to cancer therapy

Thursday, September 3rd, 2015

Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years. “I have a wonderful life. I’ve had an exotic life, an eclectic life,” explained Hach. It is a life that recently included chemotherapy to address advanced colon cancer. Emily Chan, M.D., Ph.D., associate professor of Medicine and a […]

New creative writing course geared for cancer community

Thursday, September 3rd, 2015

Cancer patients, family members and those who care for cancer patients often need a way to express the deep and often lasting emotions that a cancer diagnosis can bring. The new “Express Yourself: Creative Writing Series” gives everyone in the cancer community an opportunity to express and share those emotions. Series participants will have the […]

Prostate cancer care in spotlight at first VU football game

Thursday, September 3rd, 2015

In the first game of the season, Vanderbilt’s football program, in conjunction with the Southeastern Conference, is kicking off a campaign to highlight prostate cancer prevention and awareness. During the Sept. 3 home opener against Western Kentucky University, the Commodores are slated to wear commemorative helmet stickers to raise awareness about the disease. Other awareness activities will […]

Bad “traffic” linked to cancer

Thursday, September 3rd, 2015

The epidermal growth factor receptor (EGFR) is activated in different locations in the cell by different proteins called ligands. Transporting ligands to the wrong places, called mistrafficking, is associated with abnormal signaling and cancer. Polarized columnar epithelial cells have an “apical” surface that faces the lumen, or body cavities, and a “basolateral” surface that faces […]

Carr, Manning honored by radiology research academy

Thursday, August 27th, 2015

Two leaders in imaging science at Vanderbilt University are among 37 recipients of the 2015 Distinguished Investigator Award from the Academy of Radiology Research (ARR), academy officials announced last week. They are J. Jeffrey Carr, M.D., M.Sc., the Cornelius Vanderbilt Professor of Radiology and Radiological Sciences, and H. Charles Manning, Ph.D., Vanderbilt Ingram Associate Professor of […]

Songs from the Heart cancer event set for Sept. 26

Thursday, August 27th, 2015

Cancer affects many families, and patients and their relatives often struggle with an effective way to describe their feelings about the illness and its aftermath. Vanderbilt-Ingram Cancer Center (VICC) and Gilda’s Club Nashville give these individuals and their health care providers an opportunity to express themselves in song through the annual Songs from the Heart […]

Arteaga lauded for cancer research contributions

Thursday, August 27th, 2015

Carlos L. Arteaga, M.D., the Donna S. Hall Professor of Breast Cancer and director of the Center for Cancer Targeted Therapies and the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been recognized for his cancer research efforts by the American-Italian Cancer Foundation (AICF). The AICF will also honor Frederick Alt, Ph.D., a Howard […]

New type of trial shows promise for several cancers

Monday, August 24th, 2015

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. The new clinical trial showed promising results in […]

Next Page »« Previous Page